Page URL:

Prostate cancer genome sequenced

14 February 2011
Appeared in BioNews 595

US researchers have sequenced the genomes of several prostate tumours providing new information that may help doctors to identify aggressive forms of the cancer and prioritise treatment.

Researchers from the Broad Institute of Harvard of MIT and Harvard and the Dana-Farber Cancer Institute in Boston sequenced the genomes of prostate tumour tissue along with unaffected tissue taken from seven men to see how DNA had been damaged or mutated in the cancer tissue.

They found that large segments of DNA had been cut out and re-inserted into new locations. This genome shuffling, not described before in prostate cancer, could shed light on how genes mutate and cause cancer development.

'Whole genome sequencing gives us fascinating new insights into a category of alterations that may be especially important in prostate cancer', said study author Dr Levi Garraway of The Broad Institute.

Because all of the tumours sequenced so far have been from patients with high risk tumours, the team is not yet able to differentiate between aggressive and benign tumours. But by sequencing more cancer patients over the next several years, the researchers hope to be able to better classify prostate cancer cases by looking at specific gene changes, allowing for earlier identification of aggressive tumours and individually tailored treatment.

The study also found a large number of novel single gene mutations in the cancer tissue, some of which could be responsible for cancer development. The researchers also hope to now isolate the numbers of potentially cancer-related genetic changes enabling them to select a few target genes and cell processes to investigate as avenues for treatment.

Prostate cancer is second only to lung cancer in terms of loss of life. It is the most prevalent cancer among British men, affecting a third of men over the age of 50 and accounting for about 10,000 deaths every year in England and Wales.


The findings were published in the journal Nature.

Genetic map of prostate cancer cracked
Daily Telegraph |  10 February 2011
Prostate cancer genome map shows genes tied to seven tumour types
Bloomberg News |  9 February 2011
Researchers sequence the genome of prostate cancer, a step forward identifying aggressive tumours
LA Times |  9 February 2011
The genomic complexity of primary human prostate cancer
Nature |  9 February 2011
29 October 2012 - by Rivka Marks-Maran 
Thousands of genetic mutations associated with pancreatic cancer have been identified in an international study...
15 May 2012 - by Dr Louisa Petchey 
Whole genome sequencing of melanoma, the deadliest form of skin cancer, has confirmed the long held belief that greater sun exposure raises cancer risk by increasing the frequency of genetic mutation. The study also identifies one gene, PREX2, that is mutated in 14 percent of cases...
16 January 2012 - by Dr Linda Wijlaars 
A rare gene variant that could increase the risk of prostate cancer has been identified by researchers in the USA. Although the variant accounts for only a small fraction of all prostate cancers, the study found it was more common in men with an inherited form of the cancer and in those who are diagnosed before the age of 55...
3 October 2011 - by Sarah Pritchard 
Sequencing tissue samples from patients with deadly forms of prostate cancer has revealed previously undefined, drug-resistant tumour types that are ten times more mutated than other varieties, report researchers. The findings could help scientists develop screening methods and treatments specific to these 'hypermutated' forms of the disease...
22 August 2011 - by Sarah Pritchard 
US researchers have made a discovery that might help doctors distinguish between benign and more aggressive forms of prostate cancer. The team reports that a difference in the genetic make-up of prostate tumours could indicate which are likely to metastasize and spread through the body, and which will be slow-growing and non-fatal...
29 March 2010 - by Dr Vivienne Raper 
Infertile men may be more likely to develop aggressive prostate cancer, according to US researchers. But The Prostate Cancer Charity warn more research is needed before firm conclusions can be drawn...
31 January 2010 - by Ruth Pidsley 
A combination of three genetic alterations that dramatically reduce chances of surviving prostate cancer have been identified by researchers at the UK's Institute of Cancer Research (ICR). It is hoped that this finding could lead to the development of a genetic test to help doctors decide how aggressively to treat tumours....
28 September 2009 - by Dr Charlotte Maden 
Four genetic studies into prostate cancer have uncovered new genetic variations associated with the disease. The information may be used to provide a more reliable indication of the risk a man has of developing prostate cancer....
18 February 2008 - by Stuart Scott 
Three studies, published in the journal Nature Genetics, have uncovered ten genes that affect a man's risk of developing prostate cancer. The researchers hope that the discoveries will form the basis of a test that will predict men's chances of developing prostate cancer, as well as providing...
21 January 2008 - by Stuart Scott 
A cheap but powerful genetic test that can identify men with a high risk of developing prostate cancer - the commonest form of cancer in males - could soon be available according to US researchers. A study published in the New England Journal of Medicine suggests that the screening...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.